Hematologic Malignancy
Early T Precursor Lymphoblastic Leukemia/Lymphoma
CI-CAN-00002566Explore in graph →
Hematologic2 active trials
- NCIt
- C199170
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00002566Explore in graph →
Clinical trials
3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04582487 | Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL | unknown | N/A | 32 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Feb 7, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Feb 7, 2024source: clinicaltrials